Method for treating thyroid disorders with a botulinum toxin
US6740321B1 · kind B1 · utility
62Cited by
12References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 2, 2000 |
| Grant date | May 25, 2004 |
| Priority date | — |
| Expiry date | Apr 30, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating hypothyroidism by local administration of a neurotoxin, such as a botulinum toxin, to a thyroid, thereby reducing an inhibitory effect upon thyroid hormone secretion. A method for treating hyperthyroidism by local administration of a neurotoxin, such as a botulinum toxin, to a sympathetic ganglion which innervates the thyroid, thereby reducing a stimulatory effect upon thyroid hormone secretion. Methods for treating calcium metabolism disorders by local administration of a neurotoxin to modulate calcitonin secretion are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.